Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Oxytocin for Emotional Responses in Healthy Women
NCT05073939Phase 1Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Apr 2021
- Primary completion
- Nov 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Oral Oxytocin with Oral Placebo (2 arms). Primary endpoints: Changes in blood oxytocin concentrations after oral oxytocin at 30 months, Effects of oral oxytocin on neural responses to emotional faces assessed by emotional faces processing task fMRI at 45 months and 3 more. Status: unknown.
02
Drugs
oxytocin
Beyond the preview
Go deeper on NCT05073939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073939.